Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See (NASDAQ:RLMD)

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?Earlier this month, Relmada Therapeutics, Inc. ( RLMD ) stock surged in value from ~$4.5 to >$7, up ~55%. The gains were triggered by the Coral Gables, Florida-based biotech's reporting Phase 2 clinical study data ...